featured
Exploring Deubiquitylase OTUD6B as a Potential Therapeutic Strategy for ccRCC With VHL Mutations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cell death & disease
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Deubiquitylase OTUD6B stabilizes the mutated pVHL and suppresses cell migration in clear cell renal cell carcinoma
Cell Death Dis 2022 Feb 02;13(2)97, K Guo, Y Wei, Z Wang, X Zhang, X Zhang, X Liu, W Wu, Z Wu, L Zhang, CP CuiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.